10/26/2021 | SP | New Issue: Barclays sells $500,000 of 9.8% autocallable fixed-coupon notes on three stocks
|
2/20/2021 | SP | New Issue: BofA prices $4.45 million contingent income buffered autocalls on three stocks
|
12/16/2016 | BKDDHY | 21st Century Oncology transaction agreement deadline pushed to Jan. 4
|
12/7/2016 | BKDDHY | Moody’s drops 21st Century Oncology, loan, notes
|
11/7/2016 | BKDDHY | Moody’s: 21st Century unaffected by missed interest payment
|
11/2/2016 | BKDDHY | S&P downgrades 21st Century
|
8/31/2016 | BKDDHY | Moody’s drops 21st Century Oncology, loans, notes
|
8/5/2016 | BKDDHY | 21st Century Oncology loan, 11% notes waiver extended through Aug. 8
|
7/22/2016 | DD | 21st Century Oncology 11% noteholders waive defaults through July 31
|
7/22/2016 | BKDDHYLM | 21st Century Oncology 11% noteholders waive defaults through July 31
|
5/17/2016 | BKDDHY | S&P cuts 21st Century Oncology, debt
|
4/5/2016 | BKDDHY | Moody’s cuts 21st Century, loans, notes
|
3/29/2016 | BKDDHY | S&P might cut 21st Century Oncology
|
4/29/2015 | HY | Market Commentary: JLL/Delta Dutch Pledgeco drives by; 21st Century trades actively; MGM off amid proxy fight
|
4/29/2015 | BKCVDDEMIGPV | Market Commentary: JLL/Delta Dutch Pledgeco drives by; 21st Century trades actively; MGM off amid proxy fight
|
4/28/2015 | HY | Market Commentary: Downsized 21st Century Oncology prices; new Micron and ZF Friedrichshafen active; MDC slides
|
4/28/2015 | BKCVDDEMIGPV | Market Commentary: Downsized 21st Century Oncology prices; new Micron and ZF Friedrichshafen active; MDC slides
|
4/28/2015 | CLHY | Market Commentary: 21st Century, Trinseo, HanesBrands break; Compusearch, RadNet, Penton Media reveal changes
|
4/28/2015 | BK | Market Commentary: 21st Century, Trinseo, HanesBrands break; Compusearch, RadNet, Penton Media reveal changes
|
4/28/2015 | HY | New Issue: 21st Century Oncology prices downsized $360 million 11% eight-year notes at par
|
4/28/2015 | HY | 21st Century Oncology cuts eight-year senior notes to $360 million, ups talk to 11% coupon at par
|
4/28/2015 | BK | 21st Century Oncology ups term B to $610 million, finalizes spread
|
4/24/2015 | HY | Market Commentary: Three-part ZF Friedrichshafen, Horizon Pharma cap $11.5 billion week, new bonds better
|
4/24/2015 | HY | 21st Century Oncology talks $400 million eight-year notes to yield in 10½% area; pricing Monday
|
4/21/2015 | HY | Market Commentary: Upsized Halcon, Lennar drive-by deals price, move up; existing Halcon paper off on new deal
|
4/21/2015 | BKCVDDEMIGPV | Market Commentary: Upsized Halcon, Lennar drive-by deals price, move up; existing Halcon paper off on new deal
|
4/21/2015 | HY | 21st Century Oncology on roadshow for $400 million eight-year notes
|
4/14/2015 | CLHY | Market Commentary: Ocwen nears par with financials update and amendment talk; Creative Artists modifies OID
|
4/14/2015 | BK | Market Commentary: Ocwen nears par with financials update and amendment talk; Creative Artists modifies OID
|
4/14/2015 | BK | 21st Century Oncology launches term loan B at Libor plus 525-550 bps
|
4/14/2015 | BKDDHY | Moody's rates 21st Century Oncology loans B1, notes Caa2
|
4/13/2015 | CLHY | Market Commentary: Top Right, Mitel Networks break; Air Medical, Concordia Healthcare, Tekni-Plex revise deals
|
4/13/2015 | BK | Market Commentary: Top Right, Mitel Networks break; Air Medical, Concordia Healthcare, Tekni-Plex revise deals
|
4/13/2015 | BK | 21st Century Oncology to launch $695 million facility on Tuesday
|
2/25/2015 | BKDDHY | Moody’s ups 21st Century Oncology
|
10/1/2014 | BKDDHY | Moody’s might lift 21st Century
|
9/26/2014 | HY | Market Commentary: Distressed bonds softer despite positive GDP; 21st Century pops on new financing; Cliffs down
|
8/5/2014 | DD | Market Commentary: Caesars bonds active, mostly off amid dueling lawsuits; coal credits climb
|
8/5/2014 | HY | Market Commentary: Caesars bonds active, mostly off amid dueling lawsuits; coal credits climb
|
8/5/2014 | BKDDHY | Moody's downgrades 21st Century Oncology
|
8/4/2014 | HY | Market Commentary: Coal space rebounds from previous week; Quiksilver, 21st Century weaken; Caesars active, soft
|
8/4/2014 | DD | Market Commentary: Coal space rebounds from previous week; Quiksilver, 21st Century weaken; Caesars active, soft
|
7/31/2014 | HY | Market Commentary: Distressed debt rattled, follows broad market; Walter Energy issues earnings, bonds weaken
|
7/31/2014 | DD | Market Commentary: Distressed debt rattled, follows broad market; Walter Energy earnings disappoint, bonds weaken
|
7/30/2014 | HY | Market Commentary: 21st Century active, strong on recapitalization news; Walter Energy dips ahead of earnings
|
7/30/2014 | DD | Market Commentary: 21st Century active, strong after recapitalization news; Walter Energy drops ahead of earnings
|
7/29/2014 | HY | Market Commentary: 21st Century ‘up smartly’ on recapitalization news; Arch sees wider loss, debt gains steam
|
7/29/2014 | DD | Market Commentary: 21st Century ‘up smartly’ after recapitalization news; Arch posts wider loss, debt gains steam
|
7/23/2014 | HY | Market Commentary: 21st Century Oncology continues rally; ACE Cash debt drifting down; J.C. Penney, Caesars mixed
|
7/23/2014 | DD | Market Commentary: 21st Century Oncology continues rally; ACE Cash debt drifting down; J.C. Penney, Caesars mixed
|
7/22/2014 | HY | Market Commentary: Toys ‘R’ Us trades actively, better; 21st Century Oncology rebounds; NII bonds firm
|
7/22/2014 | DD | Market Commentary: Toys ‘R’ Us trades actively, better; 21st Century Oncology rebounds; NII Holdings bonds firm
|
7/21/2014 | HY | Market Commentary: 21st Century Oncology stays on radar; NII Holdings bonds soften; retail mixed, coal weaker
|
7/21/2014 | DD | Market Commentary: 21st Century Oncology debt stays on radar; NII Holdings bonds soften; retail mixed, coal weaker
|
7/18/2014 | HY | Market Commentary: Bid-wanteds weigh on distressed space; 21st Century Oncology weakens; TXU volatility calms
|
7/18/2014 | DD | Market Commentary: Bid-wanteds weigh on distressed space; 21st Century Oncology debt weaker; TXU volatility calms
|
7/17/2014 | HY | Market Commentary: Distressed debt pressured by Malaysian Air crash; Verso’s exchange offer fails to entice
|
7/17/2014 | DD | Market Commentary: Distressed debt pressured by Malaysian Air crash; Verso exchange offer fails to entice holders
|
7/9/2014 | HY | Market Commentary: Distressed bonds mixed, Fed minutes released; 21st Oncology rebounds; Walter Energy rises
|
7/9/2014 | DD | Market Commentary: Distressed bonds mixed, Fed minutes released; 21st Oncology rebounds; Walter Energy debt rises
|
7/8/2014 | DD | Market Commentary: Walter Energy debt weaker as new add-on priced at discount; Verso downgraded, bonds end softer
|
5/22/2014 | BK | 21st Century Oncology pulls $430 million term B with IPO postponement
|
5/22/2014 | BK | Market Commentary: Floatel, Authentic Brands, Vocus, Albaugh, SunEdison, Wyle, EnergySolutions, Genex break
|
5/9/2014 | BK | Moody's might up 21st Century, rates loans Ba3
|
5/8/2014 | BK | 21st Century talks $430 million term B at Libor plus 425-450 bps
|
5/8/2014 | BK | S&P rates 21st Century Oncology loans B-
|
5/6/2014 | BK | 21st Century Oncology to launch $640 million facility on Wednesday
|
5/6/2014 | BK | Market Commentary: Dex Media up on quarterly numbers; Hoffmaster, Eddie Bauer break; TASC reworks tranche sizes
|